16 June 2022 in Gynecology Obstetrics & Reproductive Medicine
OBJECTIVE: Aberrant right subclavian artery, which is detected in 1-1.5% of the population, is considered an anatomical variant. Aberrant right subclavian artery is usually not symptomatic, but can sometimes lead to dysphagia due to esophageal compression. On the other hand, it has been found that it has accompanied some fetal anomalies in the last two decades. Although aberrant right subclavian artery is seen at a rate of 1-1.5% in normal chromosomal fetuses, it is seen at a rate of 19-36%, especially in fetuses with Down syndrome. STUDY DESIGN: Our study was carried out in the Department of Obstetrics and Gynaecology at Ankara University Faculty of Medicine between the dates of January 2017-January 2020. Pregnant women have had their detailed ultrasonography at our clinic and who were between 18th-24th gestational weeks were included. Amniocentesis was performed on the patients who have accepted, and genetic results were followed up. The patients who did not accept were followed up until after birth, and genetic testing was requested for babies suggestive of anomaly. RESULTS: Our study included 6205 patients who underwent detailed ultrasonography in our clinic between January 2017 and June 2020. Our detailed ultrasonography application week was between 16-24 weeks. During this period, aberrant right subclavian artery was detected in 47 of our patients. The detection rate of ARSA in the normal population in our study was 0.7% (46/6205). While aberrant right subclavian artery was the only ultrasonographic finding in 28 patients, extra anomalies were observed in 18 patients. Down syndrome was detected in four fetuses, CONCLUSION: We did not find any chromosomal anomalies in any of the patients with isolated aberrant right subclavian artery. Therefore, we do not recommend invasive intervention in patients with isolated aberrant right subclavian artery. On the other hand, our study confirmed that aberrant right subclavian artery screening should be a part of a detailed fetal ultrasonographic examination. Further studies with larger patient groups are needed.
29 March 2022 in Türk Kadın Sağlığı ve Neonatoloji Dergisi
Amaç: İkinci trimesterde nukal fold (NF) kalınlık artışı saptanan fetüslerin antenatal ve doğum sonrası sonuçlarını ortaya çıkartmak. Gereç ve Yöntem: Ocak 2014- Ocak 2021 yılları arasında ayrıntılı ultrasonografi için başvuran gebelerden NF kalınlığı saptanan 45 gebe çalışmaya alındı. NF kalınlık artışı saptanan tüm gebelere amniyosentez (A/S) önerildi. A/S’yi kabul etmeyen gebelerin bebeklerinde doğum sonrası anormal bulgu saptanması durumunda genetik test istendi. Ayrıca NF kalınlık artışı saptanan gebelere fetal ekokardiyografi dahil olmak üzere ayrıntılı ultrasonografi yapıldı. Antenatal ve doğum sonrası eşlik eden yüz anomalileri, kardiyovasküler, kraniyal, gastrointestinal, genitoüriner ve iskelet sistemi patolojiler kaydedildi. Bulgular: NF kalınlık artışı saptanan 45 hastadan 13’ üne antenatal genetik test (9 A/S, 4 koriyon villus örneklenmesi (CVS)) yapıldı. Üç hastada antenatal, üç hastada postnatal olmak üzere 6 (%13,3) hastada genetik anormallik saptandı. Bu fetüslerden %6,6’sında Trizomi 21 (n:3, biri mozaizm), %2,2’sinde (n:1) ring 18 kromozom saptandı. Ayrıca bir Noonan Sendromu ve bir Genito-pateller Sendromlu hastaya postnatal tanı konuldu. Fetüslerden %28’ sinde izole NF kalınlığı saptandı. Bu fetüslerde kromozomal ve yapısal anomali saptanmadı. Gebelerin %30’unda (14/45) kardiyovasküler sistem anomalisi, %20’ sinde (9/45) yüz anomalisi, %18’inde (8/45) genitoüriner sistem, %13’inde (6/45) kraniyal, %11’inde (5/45) ekstremite anomalisi saptandı. Sonuç: Nukal fold kalınlık artışı saptanan gebelere ayrıntılı ultrasonografı yapılmalı ve genetik inceleme önerilmelidir. Eşlik eden ultrasonografik bulgu saptanması durumunda kromozomal anomali ihtimali artmaktadır. Ancak izole NF kalınlık artışı saptanması durumunda kromozomal anomali riski düşüktür. Ayrıca genetik inceleme sonucu kromozomal anomali saptanmasa bile, hastalar postnatal dönemde olası kardiyak, kraniyal, genitoüriner ve iskelet sistemi patolojileri açısından bilgilendirilmelidir.
20 January 2023 in Journal of Ankara University Faculty of Medicine
25 November 2023 in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Objective: Craniorachischisis is a rare and severe variant of neural tube defects (NTDs). It occurs in 0.51 of every 10,000 pregnancies. There is no reported etiology for this fetal abnormality. It frequently coexists with other anomalies and is believed to result from a genetic defect. To our knowledge, this report will be the first reported from a single institution in the literature on craniorachischisis. Material and methods: We present six cases diagnosed with craniorachisis in our clinic in the last 13 years, whose definitive diagnosis was clarified by necroscopy. Results: Craniorachisis is still a vital anomaly because it is a severe anomaly itself and the rate of accompanying other abnormalities is high. Fully elucidating the cause can also be a guide for other. Conclusion: Craniorachischisis can be diagnosed in the first trimester. The vertebral column should especially be examined in patients diagnosed with exencephaly. The heart, extremities, and thoracic-abdomen should be carefully examined when craniorachischisis is diagnosed. The rate of other anomalies accompanying is high. In future research, if the cause of craniorachischisis is understood, it will provide an understanding of the cause of other accompanying this anomaly.